Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 447 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
1997Preoperative endoscopic grading of esophagitis versus outcome after laparoscopic Nissen fundoplicationWatson, D.; Foreman, D.; Devitt, P.; Jamieson, G.
2002Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancerRicciardelli, C.; Brooks, J.; Suwiwat, S.; Sakko, A.; Mayne, K.; Raymond, W.; Seshadri, R.; LeBaron, R.; Horsfall, D.
2013Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-c and extracellular cyclic guanosine 3′,5′-monophosphateCastro, J.; Harrington, A.; Hughes, P.; Martin, C.; Ge, P.; Shea, C.; Jin, H.; Jacobson, S.; Hannig, G.; Mann, E.; Cohen, M.; MacDougall, J.; Lavins, B.; Kurtz, C.; Silos-Santiago, I.; Johnston, J.; Blackshaw, L.; Brierley, S.
2000Shoulder appearances at MR imaging in long-term dialysis recipientsSlavotinek, J.; Coates, P.; McDonald, S.; Disney, A.; Sage, M.
2003Time to hospital admission for acute stroke: an observational studyBroadley, S.; Thompson, P.
1996The taste of intravenous thiopentoneNor, N.; Fox, M.A.; Metcalfe, I.; Russell, W.
2011Effect of sex on symptoms associated with gastroesophageal refluxChen, Z.; Thompson, S.; Jamieson, G.; Devitt, P.; Watson, D.
2001A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriersWang, W.; Spurdle, A.; Kolachana, P.; Bove, B.; Modan, B.; Ebbers, S.; Suthers, G.; Tucker, M.; Kaufman, D.; Doody, M.; Tarone, R.; Daly, M.; Levavi, H.; Pierce, H.; Chetrit, A.; Yechezkel, G.; Chenevix-Trench, G.; Offit, K.; Godwin, A.; Struewing, J.
2010Systematic care for asthma in Australian general practice: a randomised controlled trialHolton, C.; Beilby, J.; Harris, M.; Harper, C.; Proudfoot, J.; Ramsay, E.; Ruffin, R.
2004Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicinBouralexis, S.; Clayer, M.; Atkins, G.; Labrinidis, A.; Hay, S.; Graves, S.; Findlay, D.; Evdokiou, A.